FDA Orange Book
Is there a generic for Tauvid?
Tauvid contains flortaucipir f-18. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Tauvid (flortaucipir f-18). The Orange Book shows its last listed patent expires May 26, 2032.
Run it in Rivvi
Map Tauvid and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Tauvid products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution, intravenous | 100ML (8.1-100mCi/ML) | Marketed (Rx) | None | 0 | None |
| solution, intravenous | 30ML (8.1-51mCi/ML) | Discontinued | None | 0 | None |
| solution, intravenous | 50ML (8.1-100mCi/ML) | Marketed (Rx) | None | 0 | None |
| solution, intravenous | 50ML (8.1-51mCi/ML) | Discontinued | None | 0 | None |
NDA 212123, held by AVID RADIOPHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Tauvid patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 8932557 | May 26, 2032 | Drug substance | None | 212123 |
Tauvid NDC codes
Questions
Is there a generic for Tauvid?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Tauvid (flortaucipir f-18). The Orange Book shows its last listed patent expires May 26, 2032.
What is the generic name for Tauvid?
The active ingredient in Tauvid is flortaucipir f-18, per the FDA Orange Book.
When does the Tauvid patent expire?
The last patent listed for Tauvid in the Orange Book expires May 26, 2032. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.